Munich, Germany

Christian Frisch

USPTO Granted Patents = 3 


 

Average Co-Inventor Count = 3.6

ph-index = 2

Forward Citations = 43(Granted Patents)


Location History:

  • Planegg, DE (2003)
  • München, DE (2015)
  • Munich, DE (2020)

Company Filing History:


Years Active: 2003-2020

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Christian Frisch: Innovator in Antibody Technology

Introduction

Christian Frisch is a notable inventor based in Munich, Germany. He has made significant contributions to the field of antibody technology, holding a total of 3 patents. His work focuses on developing complex-specific antibodies and innovative screening strategies for identifying binders that target enzymatic antigens.

Latest Patents

Frisch's latest patents include groundbreaking inventions such as "Complex-specific antibodies and antibody fragments and its use." This invention provides antibodies and fragments that specifically detect the complex of a cognate antigen-binding moiety and its antigen. The antibodies disclosed do not bind to either the cognate antigen-binding moiety or the antigen alone, allowing for direct detection of antigen-bound antigen-binding moieties. Another significant patent is related to "Screening strategies for the identification of binders." This invention reveals novel strategies for identifying binders that target the active site of enzymatic antigens, specifically focusing on the NS2B-NS3 Proteinase of the West Nile Virus. The antigen-binding moieties developed have numerous therapeutic and diagnostic applications.

Career Highlights

Christian Frisch is currently associated with Morphosys AG, a leading biotechnology company. His work at Morphosys AG has positioned him as a key player in the development of innovative antibody technologies.

Collaborations

Frisch collaborates with esteemed colleagues such as Achim Knappik and Titus Kretzschmar, contributing to the advancement of research in antibody technology.

Conclusion

Christian Frisch's contributions to the field of antibody technology are noteworthy, with his innovative patents paving the way for advancements in therapeutic and diagnostic applications. His work continues to impact the scientific community positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…